The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Regulation of apoptosis at cell division by p34 cdc2 phosphorylation of survivin
Open accessAbstract
The interface between apoptosis (programmed cell death) and the cell cycle is essential to preserve homeostasis and genomic integrity. Here, we show that survivin, an inhibitor of apoptosis over-expressed in cancer, physically associates with the cyclin-dependent kinase p34 cdc2 on the mitotic apparatus, and is phosphorylated on Thr 34 by p34 cdc2 -cyclin B1, in vitro and in vivo . Loss of phosphorylation on Thr 34 resulted in dissociation of a survivin-caspase-9 complex on the mitotic apparatus, and caspase-9-dependent apoptosis of cells traversing mitosis. These data identify survivin as a mitotic substrate of p34 cdc2 -cyclin B1 and suggest that survivin phosphorylation on Thr 34 may be required to preserve cell viability at cell division. Manipulation of this pathway may facilitate the elimination of cancer cells at mitosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thornberry, N. A., & Lazebnik, Y. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,887
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165
Self-citationIAP family proteins---suppressors of apoptosis
Deveraux, Q. L., & Reed, J. C. (1999) · Genes & Development · doi:10.1101/gad.13.3.239 · Cited by 2,551
Boldin, M. P., Goncharov, T. M., Goltseve, Y. V., & Wallach, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81265-9 · Cited by 2,292
Control of apoptosis and mitotic spindle checkpoint by survivin
Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., & Altieri, D. C. (1998) · Nature · doi:10.1038/25141 · Cited by 1,870
Self-citationVaux, D. L., & Korsmeyer, S. J. (1999) · Cell · doi:10.1016/s0092-8674(00)80564-4 · Cited by 1,570
A Matter of Life and Cell Death
Evan, G., & Littlewood, T. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,523
Green, D. R. (1998) · Cell · doi:10.1016/s0092-8674(00)81728-6 · Cited by 1,196
Distinct Roles for Cyclin-Dependent Kinases in Cell Cycle Control
van den Heuvel, S., & Harlow, E. (1993) · Science · doi:10.1126/science.8266103 · Cited by 1,092
14-3-3σ is required to prevent mitotic catastrophe after DNA damage
Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Nature · doi:10.1038/44188 · Cited by 895
Cited by
Validating survivin as a cancer therapeutic target
Altieri, D. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc968 · Cited by 1,206
Self-citationSurvivin, cancer networks and pathway-directed drug discovery
Altieri, D. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2293 · Cited by 994
Self-citationBollrath, J., Phesse, T. J., von Burstin, V. A., Putoczki, T., Bennecke, M., Bateman, T., Nebelsiek, T., Lundgren-May, T., Canli, Ö., Schwitalla, S., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.002 · Cited by 946
“In untransformed cells, survivin is selectively expressed during the G2/M transition, localizes to mitotic spindle microtubules (Li et al., 1998), and is phosphorylated by physical association with cdc2 (O’Connor et al., 2000), while siRNA-mediated (A–”
BackgroundThe chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis
Carmena, M., Wheelock, M., Funabiki, H., & Earnshaw, W. C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3474 · Cited by 905
Survivin, versatile modulation of cell division and apoptosis in cancer
Altieri, D. C. (2003) · Oncogene · doi:10.1038/sj.onc.1207113 · Cited by 900
Self-citationTranscriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53
Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J., & Murphy, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106643200 · Cited by 794
The inhibitors of apoptosis (IAPs) as cancer targets
Hunter, A. M., LaCasse, E. C., & Korneluk, R. G. (2007) · Apoptosis · doi:10.1007/s10495-007-0087-3 · Cited by 565
Taxanes, microtubules and chemoresistant breast cancer
McGrogan, B. T., Gilmartin, B., Carney, D. N., & McCann, A. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.10.004 · Cited by 535
IAP-targeted therapies for cancer
LaCasse, E. C., Mahoney, D. J., Cheung, H. H., Plenchette, S., Baird, S., & Korneluk, R. G. (2008) · Oncogene · doi:10.1038/onc.2008.302 · Cited by 524
Nakahara, T., Takeuchi, M., Kinoyama, I., Minematsu, T., Shirasuna, K., Matsuhisa, A., Kita, A., Tominaga, F., Yamanaka, K., Kudoh, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1343 · Cited by 497
Microtubules, microtubule-interfering agents and apoptosis
Mollinedo, F., & Gajate, C. (2003) · Apoptosis · doi:10.1023/a:1025513106330 · Cited by 477
Microtubule-targeted anticancer agents and apoptosis
Bhalla, K. N. (2003) · Oncogene · doi:10.1038/sj.onc.1207233 · Cited by 461
HBXIP functions as a cofactor of survivin in apoptosis suppression
Marusawa, H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg263 · Cited by 432
Roberson, R. S., Kussick, S. J., Vallieres, E., Chen, S.-Y. J., & Wu, D. Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1270 · Cited by 428
The molecular basis and potential role of survivin in cancer diagnosis and therapy
Altieri, D. C. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02243-2 · Cited by 412
Self-citationMitochondrial survivin inhibits apoptosis and promotes tumorigenesis
Dohi, T., Beltrami, E., Wall, N. R., Plescia, J., & Altieri, D. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422222 · Cited by 405
Self-citationApoptosis-based therapies for hematologic malignancies
Reed, J. C., & Pellecchia, M. (2005) · Blood · doi:10.1182/blood-2004-07-2761 · Cited by 402
Survivin: A new target for anti-cancer therapy
Ryan, B. M., O’Donovan, N., & Duffy, M. J. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.05.003 · Cited by 379
Survivin and IAP proteins in cell-death mechanisms
Altieri, D. C. (2010) · Biochemical Journal · doi:10.1042/bj20100814 · Cited by 376
Self-citationApoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
Neophytou, C. M., Trougakos, I. P., Erin, N., & Papageorgis, P. (2021) · Cancers · doi:10.3390/cancers13174363 · Cited by 371
McMurtry, M. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23203 · Cited by 368
Song, Z., Yao, X., & Wu, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300957200 · Cited by 363
Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe
Castedo, M., Perfettini, J.-L., Roumier, T., & Kroemer, G. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401130 · Cited by 345
Cancer gene therapy using a survivin mutant adenovirus
Mesri, M., Wall, N. R., Li, J., Kim, R. W., & Altieri, D. C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12983 · Cited by 337
Self-citationWheatley, S. P., & Altieri, D. C. (2019) · Journal of Cell Science · doi:10.1242/jcs.223826 · Cited by 337
Self-citationZeitlin, S. G., Shelby, R. D., & Sullivan, K. F. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200108125 · Cited by 330
Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC
Goga, A., Yang, D., Tward, A. D., Morgan, D. O., & Bishop, J. M. (2007) · Nature Medicine · doi:10.1038/nm1606 · Cited by 326
Phosphoproteome analysis of the human mitotic spindle
Nousiainen, M., Silljé, H. H. W., Sauer, G., Nigg, E. A., & Körner, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507066103 · Cited by 324
Bolton, M. A., Lan, W., Powers, S. E., McCleland, M. L., Kuang, J., & Stukenberg, P. T. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0092 · Cited by 321
A p34cdc2 survival checkpoint in cancer
O'Connor, D. S., Wall, N. R., Porter, A. C. G., & Altieri, D. C. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00084-3 · Cited by 315
Self-citationChromosomal passengers: the four-dimensional regulation of mitotic events
Vagnarelli, P., & Earnshaw, W. C. (2004) · Chromosoma · doi:10.1007/s00412-004-0307-3 · Cited by 314
Survivin study: What is the next wave?
Li, F. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10327 · Cited by 309
Self-citationFortugno, P., Wall, N. R., Giodini, A., O'Connor, D. S., Plescia, J., Padgett, K. M., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.3.575 · Cited by 307
Self-citationMa, H., Nguyen, C., Lee, K.-S., & Kahn, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208433 · Cited by 307
The Role of Apoptosis in the Regulation of Trophoblast Survival and Differentiation during Pregnancy
Straszewski-Chavez, S. L., Abrahams, V. M., & Mor, G. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0003 · Cited by 307
Inhibition of melanoma tumor growth in vivo by survivin targeting
Grossman, D., Kim, P. J., Schechner, J. S., & Altieri, D. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.635 · Cited by 286
Self-citationThe case for survivin as a regulator of microtubule dynamics and cell-death decisions
Altieri, D. C. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.08.015 · Cited by 284
Self-citationCharacterization of Fortilin, a Novel Antiapoptotic Protein
Li, F., Zhang, D., & Fujise, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108954200 · Cited by 282
Self-citationSchmidt, S. M., Schag, K., Müller, M. R., Weck, M. M., Appel, S., Kanz, L., Grünebach, F., & Brossart, P. (2003) · Blood · doi:10.1182/blood-2002-08-2554 · Cited by 277
Zaffaroni, N., Pennati, M., Colella, G., Perego, P., Supino, R., Gatti, L., Pilotti, S., Zunino, F., & Daidone, M. G. (2002) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-002-8518-3 · Cited by 275
Tao, W., South, V. J., Zhang, Y., Davide, J. P., Farrell, L., Kohl, N. E., Sepp-Lorenzino, L., & Lobell, R. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.003 · Cited by 273
Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance
Xie, B., Wang, S., Jiang, N., & Li, J. J. (2019) · Cancer Letters · doi:10.1016/j.canlet.2018.11.019 · Cited by 261
Sustained Survivin Expression from OX40 Costimulatory Signals Drives T Cell Clonal Expansion
Song, J., So, T., Cheng, M., Tang, X., & Croft, M. (2005) · Immunity · doi:10.1016/j.immuni.2005.03.012 · Cited by 256
Current status of the molecular mechanisms of anticancer drug-induced apoptosis
Kim, R., Tanabe, K., Uchida, Y., Emi, M., Inoue, H., & Toge, T. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0522-7 · Cited by 253
Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease?
Aziz, M. H., Reagan‐Shaw, S., Wu, J., Longley, B. J., & Ahmad, N. (2005) · The FASEB Journal · doi:10.1096/fj.04-3582fje · Cited by 220
Apoptosis regulators and responses in human melanocytic and keratinocytic cells
Bowen, A. R., Hanks, A. N., Allen, S. M., Alexander, A., Diedrich, M. J., & Grossman, D. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12010.x · Cited by 149
Self-citationPolyploidy road to therapy‐induced cellular senescence and escape
Wang, Q., Wu, P. C., Dong, D. Z., Ivanova, I., Chu, E., Zeliadt, S., Vesselle, H., & Wu, D. Y. (2013) · International Journal of Cancer · doi:10.1002/ijc.27810 · Cited by 129
Metadata
- Authors
- O'Connor, D. S., Grossman, D., Plescia, J., Li, F., Zhang, H., Villa, A., Tognin, S., Marchisio, P. C., & Altieri, D. C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-11-07
- Volume
- 97
- Issue
- 24
- Pages
- 13103-13107
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1981006523
- Cited by
- 611
- References
- 30
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.